{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:52:10Z","timestamp":1776167530805,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241046"],"award-info":[{"award-number":["BK20241046"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["25KJD310004"],"award-info":[{"award-number":["25KJD310004"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019356","name":"Research and Innovation in Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018636","name":"Xuzhou Science and Technology Program","doi-asserted-by":"publisher","award":["KC25105"],"award-info":[{"award-number":["KC25105"]}],"id":[{"id":"10.13039\/501100018636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.intimp.2026.116527","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:44:36Z","timestamp":1773971076000},"page":"116527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K\/Akt\/mTOR pathway"],"prefix":"10.1016","volume":"177","author":[{"given":"Xiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116527_bb0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2026.116527_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2012.115","article-title":"Childhood nephrotic syndrome--current and future therapies","volume":"8","author":"Greenbaum","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2026.116527_bb0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0090-9556(24)15298-1","article-title":"The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects","volume":"27","author":"Moller","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2026.116527_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03192295","article-title":"Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients","volume":"23","author":"Wallemacq","year":"1998","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.intimp.2026.116527_bb0025","first-page":"2760","article-title":"Uptake of FK 506 by lymphocytes and erythrocytes","volume":"23","author":"Kay","year":"1991","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.intimp.2026.116527_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jps.2600820325","article-title":"Plasma protein binding of tacrolimus in humans","volume":"82","author":"Piekoszewski","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2026.116527_bb0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/phar.2836","article-title":"External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant","volume":"43","author":"Rower","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2026.116527_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1090455","article-title":"Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels","volume":"12","author":"Hu","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.intimp.2026.116527_bb0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00228-024-03717-2","article-title":"Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach","volume":"80","author":"Yang","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14791","article-title":"BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients","volume":"28","author":"Huang","year":"2024","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.intimp.2026.116527_bb0055","article-title":"Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jcpt.13072","article-title":"Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule","volume":"45","author":"Chen","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.intimp.2026.116527_bb0065","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3892\/etm.2020.8821","article-title":"Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2026.116527_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/phar.2749","article-title":"Tacrolimus in the treatment of childhood nephrotic syndrome: machine learning detects novel biomarkers and predicts efficacy","volume":"43","author":"Mo","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2026.116527_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jocn.2023.08.022","article-title":"Long-term efficacy and safety of tacrolimus in young children with myasthenia gravis","volume":"116","author":"Zhang","year":"2023","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.intimp.2026.116527_bb0080","first-page":"4653","article-title":"Population pharmacokinetics of tacrolimus in pediatric patients with systemic-onset juvenile idiopathic arthritis: initial dosage recommendations","volume":"18","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2026.116527_bb0085","first-page":"116","article-title":"Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients","volume":"13","author":"Dehghani","year":"2010","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.intimp.2026.116527_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6539","article-title":"Hypertrophic cardiomyopathy secondary to tacrolimus therapy in a kidney transplant patient: a case report and focused review of the literature","volume":"10","author":"Hernandez Silva","year":"2022","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.intimp.2026.116527_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/1516-3180.2013.1313472","article-title":"A case of tacrolimus-induced supraventricular arrhythmia after kidney transplantation","volume":"131","author":"Kim","year":"2013","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.intimp.2026.116527_bb0100","first-page":"1352","article-title":"Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient","volume":"125","author":"Liu","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.intimp.2026.116527_bb0105","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/rheumatology\/kex310","article-title":"Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis","volume":"56","author":"Noda","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2026.116527_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(95)91357-2","article-title":"Tacrolimus and cardiotoxicity in adult liver transplant recipients","volume":"346","author":"Dollinger","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116527_bb0115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1345\/aph.10299","article-title":"Lack of tacrolimus-induced cardiomyopathy","volume":"35","author":"Coley","year":"2001","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116527_bb0120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(95)90011-X","article-title":"Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients","volume":"345","author":"Atkison","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116527_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3046.2001.00052.x","article-title":"Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation","volume":"5","author":"Chang","year":"2001","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.intimp.2026.116527_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1399-3046.2000.00083.x","article-title":"Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy","volume":"4","author":"Pappas","year":"2000","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.intimp.2026.116527_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194985","article-title":"Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.116527_bb0140","first-page":"964","article-title":"LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-beta1\/Smad3\/NF-kappaB pathway","volume":"25","author":"Luo","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.intimp.2026.116527_bb0145","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12033-023-00697-z","article-title":"The role of epithelial mesenchymal transition (EMT) in pathogenesis of cardiotoxicity: Diagnostic & Prognostic Approach","volume":"65","author":"Kardooni","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116527_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.116015","article-title":"Downregulation of PDZK1 by TGF-beta1 promotes renal fibrosis via inducing epithelial-mesenchymal transition of renal tubular cells","volume":"220","author":"Lu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2024.04.005","article-title":"Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis","volume":"271","author":"Song","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2026.116527_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111650","article-title":"Forsythiaside a suppresses renal fibrosis and partial epithelial-mesenchymal transition by targeting THBS1 through the PI3K\/AKT signaling pathway","volume":"129","author":"Tuoheti","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0165","doi-asserted-by":"crossref","first-page":"2316259","DOI":"10.1080\/0886022X.2024.2316259","article-title":"Kruppel-like factor 4 modulates the miR-101\/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial-mesenchymal transition","volume":"46","author":"Zhao","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.intimp.2026.116527_bb0170","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1002\/tox.24229","article-title":"Nickel induces epithelial-mesenchymal transition in pulmonary fibrosis in mice via activation of the oxidative stress-mediated TGF-beta1\/Smad signaling pathway","volume":"39","author":"Cao","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.intimp.2026.116527_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116949","article-title":"Melatonin prevents pulmonary fibrosis caused by PM(2.5) exposure by targeting epithelial-mesenchymal transition","volume":"487","author":"Chen","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112563","article-title":"Hydrogen combined with tetrandrine attenuates silica-induced pulmonary fibrosis via suppressing NF-kappaB\/NLRP3 signaling pathway-mediated epithelial mesenchymal transition and inflammation","volume":"138","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.134560","article-title":"Benzo[a]pyrene evokes epithelial-mesenchymal transition and pulmonary fibrosis through AhR-mediated Nrf2-p62 signaling","volume":"473","author":"Li","year":"2024","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.intimp.2026.116527_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2024.105971","article-title":"Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2\/ERK\/p38 axis","volume":"202","author":"Zhao","year":"2024","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.intimp.2026.116527_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116124","article-title":"Dibutyl phthalate (DBP) promotes epithelial-mesenchymal transition (EMT) to aggravate liver fibrosis into cirrhosis and portal hypertension (PHT) via ROS\/TGF-beta1\/Snail-1 signalling pathway in adult rats","volume":"274","author":"Chen","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2026.116527_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300529","article-title":"Nobiletin alleviated epithelial-mesenchymal transition of hepatocytes in liver fibrosis based on autophagy-hippo\/YAP pathway","volume":"68","author":"Hao","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.intimp.2026.116527_bb0205","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s12011-024-04294-2","article-title":"TGF-beta\/SMAD pathway mediates cadmium poisoning-induced chicken liver fibrosis and epithelial-mesenchymal transition","volume":"203","author":"Zhang","year":"2025","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.intimp.2026.116527_bb0210","first-page":"633","article-title":"Effect of epithelial-mesenchymal transition on cardiac fibrosis induced by oil mist particulate matter","volume":"38","author":"Liu","year":"2022","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.intimp.2026.116527_bb0215","doi-asserted-by":"crossref","first-page":"2326022","DOI":"10.1080\/10641963.2024.2326022","article-title":"Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS\/PI3K\/Akt\/mTOR axis","volume":"46","author":"Huang","year":"2024","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.intimp.2026.116527_bb0220","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.18632\/aging.202482","article-title":"QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K\/AKT\/mTOR pathway","volume":"13","author":"Lv","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2026.116527_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132896","article-title":"Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy","volume":"273","author":"Qi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2026.116527_bb0230","doi-asserted-by":"crossref","first-page":"2195305","DOI":"10.1080\/15592294.2023.2195305","article-title":"LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K\/Akt\/mTOR pathway","volume":"18","author":"Qi","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.intimp.2026.116527_bb0235","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/jgh.16538","article-title":"Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K\/Akt\/mTOR pathway","volume":"39","author":"Wang","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.116527_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/acer.15021","article-title":"Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K\/AKT\/mTOR pathway in mice","volume":"47","author":"Meng","year":"2023","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"10.1016\/j.intimp.2026.116527_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.778479","article-title":"Inhibition of PI3K\/AKT\/mTOR signalling pathway activates autophagy and suppresses peritoneal fibrosis in the process of peritoneal Dialysis","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.116527_bb0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/rej.2018.2104","article-title":"Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K\/Akt\/mTOR Signaling pathway in vivo and in vitro","volume":"22","author":"Dou","year":"2019","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.intimp.2026.116527_bb0255","first-page":"443","article-title":"Nrf3 promotes the proliferation and migration of triple-negative breast cancer by activating PI3K\/AKT\/mTOR and epithelial-mesenchymal transition","volume":"26","author":"Chen","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2026.116527_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13560","article-title":"CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K\/Akt\/mTOR and autophagy pathways","volume":"57","author":"Xu","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.intimp.2026.116527_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12935-024-03454-7","article-title":"TGFBI promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through PI3K\/AKT\/mTOR\/HIF-1alpha pathway","volume":"24","author":"Zhan","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.116527_bb0270","article-title":"The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.116527_bb0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbcan.2019.01.005","article-title":"Potential roles and targeted therapy of the CXCLs\/CXCR2 axis in cancer and inflammatory diseases","volume":"1871","author":"Cheng","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116527_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156675","article-title":"The CXCR2 chemokine receptor: a new target for gastric cancer therapy","volume":"181","author":"Kang","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2026.116527_bb0285","doi-asserted-by":"crossref","first-page":"14142","DOI":"10.1038\/s41598-024-64780-4","article-title":"A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy","volume":"14","author":"Shao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116527_bb0290","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.7150\/jca.92588","article-title":"S100A8-mediated inflammatory Signaling drives colorectal Cancer progression via the CXCL5\/CXCR2 Axis","volume":"15","author":"Chen","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2026.116527_bb0295","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318534121","article-title":"CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance","volume":"121","author":"Banuelos","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116527_bb0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-024-02984-2","article-title":"Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001","volume":"43","author":"Montemagno","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116527_bb0305","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0172-2023","article-title":"A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome","volume":"33","author":"Toya","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.intimp.2026.116527_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071536","article-title":"Cerebral endothelial CXCR2 promotes neutrophil transmigration into central nervous system in LPS-induced septic encephalopathy","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116527_bb0315","first-page":"2060","article-title":"CXCL8 and its cognate receptors CXCR1\/CXCR2 in primary myelofibrosis","volume":"109","author":"Vermeersch","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2026.116527_bb0320","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.surg.2023.12.018","article-title":"Inhibition of chemokine receptor CXCR2 attenuates postoperative peritoneal adhesion formation","volume":"175","author":"Su","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.intimp.2026.116527_bb0325","first-page":"2181","article-title":"Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116527_bb0330","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bph.12467","article-title":"Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis","volume":"171","author":"Dornelles","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116527_bb0335","doi-asserted-by":"crossref","first-page":"F1422","DOI":"10.1152\/ajprenal.00319.2013","article-title":"CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation","volume":"305","author":"Ranganathan","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2026.116527_bb0340","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1096\/fj.201700895R","article-title":"Mesenchymal stem cells promote endothelial progenitor cell migration, vascularization, and bone repair in tissue-engineered constructs via activating CXCR2-Src-PKL\/Vav2-Rac1","volume":"32","author":"Li","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2026.116527_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011733","article-title":"HIV-1 inhibits autophagy in bystander macrophage\/monocytic cells through Src-Akt and STAT3","volume":"5","author":"Van Grol","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2026.116527_bb0350","doi-asserted-by":"crossref","first-page":"85628","DOI":"10.18632\/oncotarget.20429","article-title":"TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src\/Akt pathway","volume":"8","author":"Yan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.116527_bb0355","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13046-018-0856-6","article-title":"TSSC3 promotes autophagy via inactivating the Src-mediated PI3K\/Akt\/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis","volume":"37","author":"Zhao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:58:35Z","timestamp":1776164315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926003723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"alternative-id":["S1567576926003723"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116527","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K\/Akt\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116527"}}